Navigation Links
Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update
Date:8/4/2009

--- ---- ---- ---- Operating expenses: Research and development 5,653 9,151 13,757 15,487 General and administrative 3,435 3,723 6,519 7,906 Restructuring & asset impairment - - 1,056 - ----- ----- ----- ----- Total operating expenses 9,088 12,874 21,332 23,393 ----- ------ ------ ------ Loss from operations (9,088) (12,874) (21,332) (23,393) ------ ------- ------- ------- Other income (expense), net (632) 343 (1,338) 1,007 ---- --- ------ ----- Net loss (9,720) (12,531) (22,670) (22,386) Preferred stock dividends (125) (125) (250) (250) ---- ---- ---- ---- Loss applicable to common shares $(9,845) $(12,656) $(22,920) $(22,636) ======= ======== ======== ======== Loss per share: Basic and diluted $(0.28) $(0.36) $(0.66) $(0.65) ====== ====== ====== ====== Shares used in calculation of loss per share: Basic and diluted 34,712 34,688 34,700 34,684 ====== ====== ====== ====== Condensed Consolidated Balance Sheets (In thousands) June 30, 2009 December 31, 2008 ------------- ----------------- (Unaudited) (Note 1) ASSETS: Cash
'/>"/>
SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Poniard Pharmaceuticals to Host Second Quarter 2009 Financial Results Conference Call on August 4
2. Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors
3. Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference
4. Poniard Pharmaceuticals Files Shelf Registration
5. Poniard Pharmaceuticals to Present at the Leerink Swann Oncology Roundtable Conference
6. Poniard Pharmaceuticals to Present at the 2009 BIO International Convention
7. Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer
8. Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Researchs 100th Annual Meeting
9. Poniard Pharmaceuticals Reschedules Fourth Quarter and Fiscal 2008 Results Conference Call for Monday, March 16
10. Poniard Pharmaceuticals to Host Fourth Quarter and Year-End 2008 Financial Results Conference Call on March 12
11. Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Using microscopic polymer light resonators that expand in ... Quantum Photonics Laboratory have developed new optical sensors ... Optical sensors are ideal for detecting trace gas ... lightweight nature, and immunity to electromagnetic interference. , ... before, the MIT team conceived an extremely sensitive, ...
(Date:7/10/2014)... fractional quantum Hall effect in bilayer graphene and shown ... by an electric field. , The fractional quantum ... thin sheets are exposed to large magnetic fields, is ... individual electrons behave as a single system. However, while ... many details of this collective behavior remain not well ...
(Date:7/10/2014)... out for crude 3-D glasses, polarized glasses, and ... basic devices, used to trick the brain into ... rendered obsolete with the introduction of new holography ... TAU doctoral students Yuval Yifat, Michal Eitan, and ... on nanoantennas that could be used for security ...
(Date:1/15/2014)... approach akin to assembling a club sandwich at ... (NIST) researchers have succeeded in crafting a uniform, ... of foam commonly used in upholstered furniture and ... nanotube-coated polyurethane foam was reduced 35 percent compared ...
Breaking Biology Technology:Swell new sensors 2Columbia researchers observe tunable quantum behavior in bilayer graphene 2Columbia researchers observe tunable quantum behavior in bilayer graphene 3Projecting a 3-dimensional future 2Projecting a 3-dimensional future 3Layered security: Carbon nanotubes promise improved flame-resistant coating 2
... Mich., Nov. 24 Terumo Heart, Inc. is pleased ... of Chief Executive,Officer (C.E.O.) and President, effective immediately. "With ... strong leadership role in,the future treatment of heart failure. ... the DuraHeart U.S. Pivotal trials in up to 40 ...
... Inc., (OTC Bulletin Board: IMDS) a pioneer in laser,optical ... of its,21st US Patent entitled "Apparatus and Method for ... Spread,Function of the Detected Light," dated November 4, 2008. ... http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO ) , ...
... Boston Scientific,Corporation (NYSE: BSX ) is scheduled to ... held December 2 - 3 in New York City. , ... 30-minute presentation on,Tuesday, December 2, beginning at approximately 8:00 a.m. ... webcast of Mr. Tobin,s remarks will be available to all ...
Cached Biology Technology:Terumo Heart Announces Appointment of William Pinon to Chief Executive Officer and President 2Imaging Diagnostic Systems is Recognized for Its Advanced Engineering in Time-Resolved Techniques by the US Patent Office 2Imaging Diagnostic Systems is Recognized for Its Advanced Engineering in Time-Resolved Techniques by the US Patent Office 3
(Date:7/10/2014)... July 2, 2014 It is a great ... the appointment of the world-renowned Thoracic and Cardiovascular surgeon, ... Dr. Ginsburg, with over 34 years of ... Hospital and Good Samaritan Regional Medical Center. Dr. Ginsburg ... late 1980,s and is considered an expert in the ...
(Date:7/10/2014)... 2014 Fingerprint Cards, (FPC,s) new mobile ... (DW). A Chinese Top 5 smartphone OEM has selected FPC1021 ... production in October 2014.   FPC is proud ... OEM, which has a planned date for the start of ... for this phone of 3 million units. The Chinese OEM ...
(Date:7/10/2014)... 2014 The widespread adoption of the ... by meaningful use and related federal programs, is ... laboratory information. Now, more than ever, pathologists need ... informatics in order to deliver high quality and ... educational needs of pathologists in this evolving health ...
Breaking Biology News(10 mins):Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2FPC Wins DW for 1021 Touch Sensor for Flagship Smartphone from Chinese Top 5 Smartphone OEM 2New Clinical Informatics Curriculum Prepares Future Pathologists 2New Clinical Informatics Curriculum Prepares Future Pathologists 3New Clinical Informatics Curriculum Prepares Future Pathologists 4
... the University of Rochester Biomedical Engineering Department has invented ... stem cells. When he captures cancer cells, he ... harvests them for later use in tissue engineering, bone ... and improve health. With Nichola Charles, Jared Kanofsky, ...
... that bacteria that cause diseases like bubonic plague and ... them infectious on or off. , Knowing how disease-causing ... may one day help scientists create drugs that control ... harmless, said Vladimir Svetlov, a study co-author and a ...
... of £23.6M a year to the UK poultry industry but ... against the disease ?one that can be delivered while they ... vaccine virus which provides immunity to IBV has been developed ... vaccine company Intervet UK. It can be delivered to chicks ...
Cached Biology News:Cancer-killing invention also harvests stem cells 2Cancer-killing invention also harvests stem cells 3Cancer-killing invention also harvests stem cells 4Bacteria control how infectious they become, study finds 2Bacteria control how infectious they become, study finds 3In-shell vaccine for chick disease 2
Human BMP 2 Construction Kit provides antigen affinity purified polyclonal capture and tracer antibodies, and antigen standard for development of approximately ten microplate assays....
...
... pAcGHLT-A,B,C Baculovirus ... Set,pAcGHLT-XylE Baculovirus ... Powder,Thrombin Dilution ... Cocktail,Insect Cell ...
...
Biology Products: